FastBreak Medical

Company Overview

Snapshot

Founded in December 2017 by Doron Bushi, FastBreak Medical operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on the development of a noninvasive wearable sensing patch for early detection of carotid stenosis.

Business overview

FastBreak Medical develops a noninvasive wearable sensing patch designed for the early detection of carotid stenosis, a significant risk factor for stroke. Their core technology involves a patch that attaches to the neck above the carotid artery, monitoring blood pressure waveforms to identify abnormal carotid pulse waves associated with the condition. The device utilizes wireless Bluetooth communication to transmit data to a user's app for analysis. The company operates within the Digital Healthcare and Medical Devices sectors, specifically targeting Digital Medical Diagnostics and Diagnostics Devices, and serves the healthcare market, including providers and patients.

Company Intelligence Q&A

What is FastBreak Medical's primary focus?

FastBreak Medical focuses on developing a noninvasive wearable sensing patch for the early detection of carotid stenosis, a key risk factor for stroke.

Who founded FastBreak Medical?

FastBreak Medical was founded by Doron Bushi in December 2017.

What technology does FastBreak Medical's product use?

The company's sensing patch uses wireless Bluetooth communication to transfer data to a user's app for analysis of blood pressure waveforms.

What stage is FastBreak Medical currently in?

FastBreak Medical is currently in the Pre-Funding stage, with its product in clinical trial.

What markets does FastBreak Medical serve?

FastBreak Medical serves the healthcare market, with a focus on providers and patients within the Digital Healthcare and Medical Devices sectors.